Fintel on MSN

JP Morgan Downgrades Rocket Pharmaceuticals (RCKT)

Fintel reports that on November 18, 2025, JP Morgan downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) from ...
Fintel on MSN

Guggenheim Maintains Centessa Pharmaceuticals plc - Depositary Receipt (CNTA) Buy Recommendation

Fintel reports that on November 18, 2025, Guggenheim maintained coverage of Centessa Pharmaceuticals plc - Depositary Receipt ...

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
American Association of Individual Investors

3 Undervalued Pharmaceuticals Stocks for Tuesday, November 18

You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...

West Pharmaceutical Services, Inc. (WST) Presents at Jefferies London Healthcare Conference 2025 Transcript

West Pharmaceutical Services, Inc. ( WST) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST ...

Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
NatureOpinion

The UK must not lose its focus on science and innovation

Can UK science really spawn a $1-trillion company? That’s not to downplay the successes. The United Kingdom is ranked fourth ...

Pharmaceuticals and Biotechnology Option and Evaluation Deals Trends Analysis Report 2025 with Directory of Deals by Company A-Z, Therapy Focus and Technology Type

The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the report provides details of ...

Pharmaceuticals Collaboration Agreements Analysis Report and Directory of Deals 2025: Track Trends, Benchmark Valuations, and Access Detailed Contract Terms from 2020 Onward

The "Collaboration Deals in Pharmaceuticals 2020-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of collaboration deals announced since 2020 as ...

Pharmaceuticals and Biotechnology Asset Purchase Agreements Analysis Report 2025: Everything a Prospective Dealmaker Needs to Know About Business, Product, Royalty, and ...

The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.The report provides access to asset purchase deal payment terms as ...

Medunik USA reaffirms support for Sickle Cell Disease community with uninterrupted supply and Patient-Centered Services

CNW/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to ...

Pharmaceuticals and Biotechnology Co-development Agreements Analysis Report 2025 with Directory of Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

The "Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of co-development deals ...